Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

LigoCyte awarded Phase II SBIR grant for nanoparticle technology

May 5, 2000

La Jolla to conduct phase III trial of lupus drug candidate

May 4, 2000

Celltech dedicates significant resources to study of integrin inhibitors

May 4, 2000

Ciba Vision to market Salagen Tablets in Europe

May 4, 2000

Effective, nonulcerogenic antiarthritic agents designed by Almirall Prodesfarma

May 3, 2000

New series of tachykinin antagonists described in patent literature by Pfizer

May 3, 2000

Inhibitors of p38 MAP kinase a focus of R&D at Vertex

April 27, 2000

New hope for patients suffering from Sjogren's syndrome: FDA approves cevimeline

April 26, 2000

Japanese scientists synthesize new series of MMP inhibitors

April 26, 2000

Ajinomoto prepares benzene derivatives useful for inflammation, etc.

April 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...